Pathogen safety profile of a 10% IgG preparation manufactured using a depth filtration-modified process. | Biologicals;40(4): 247-53, 2012 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Pathogen safety profile of a 10% IgG preparation manufactured using a depth filtration-modified process.

Barnette, Deborah; Roth, Nathan J; Hotta, Joann; Cai, Kang; Gall, Michelle; Hartwell, Randy; Kent, Jonathan D; Willis, Todd.

Affiliation

Barnette D; Grifols Therapeutics Inc, 79 TW Alexander Drive, Research Triangle Park, NC 27709, USA. deborah.barnette@grifols.com

Biologicals ; 40(4): 247-53, 2012 Jul.

Article in En | MEDLINE | ID: mdl-22579294

Subject(s)

Filtration/methods; Immunoglobulin G; Prions/isolation & purification; Viruses/isolation & purification

Search on Google

Full text: 1 Database: MEDLINE Main subject: Viruses / Prions / Immunoglobulin G / Filtration Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2012 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Database: MEDLINE Main subject: Viruses / Prions / Immunoglobulin G / Filtration Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2012 Type: Article Affiliation country: United States